Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 12 | 2024 | 361 | 1.470 |
Why?
|
| Catheter Ablation | 9 | 2024 | 256 | 1.290 |
Why?
|
| Atrial Appendage | 2 | 2024 | 35 | 0.810 |
Why?
|
| Pulmonary Veins | 5 | 2024 | 93 | 0.650 |
Why?
|
| Septal Occluder Device | 1 | 2018 | 51 | 0.580 |
Why?
|
| Esophagus | 3 | 2024 | 107 | 0.430 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2020 | 275 | 0.270 |
Why?
|
| Electrocardiography | 7 | 2020 | 498 | 0.230 |
Why?
|
| Heart Atria | 3 | 2023 | 285 | 0.230 |
Why?
|
| Predictive Value of Tests | 4 | 2024 | 1747 | 0.230 |
Why?
|
| Conscious Sedation | 1 | 2024 | 70 | 0.230 |
Why?
|
| Cryosurgery | 2 | 2020 | 58 | 0.220 |
Why?
|
| Esophageal Fistula | 1 | 2023 | 11 | 0.220 |
Why?
|
| Anesthesia, General | 1 | 2024 | 118 | 0.220 |
Why?
|
| Registries | 2 | 2024 | 812 | 0.200 |
Why?
|
| Tachycardia, Ventricular | 5 | 2002 | 124 | 0.200 |
Why?
|
| Treatment Outcome | 8 | 2024 | 8379 | 0.190 |
Why?
|
| Hypothermia, Induced | 1 | 2022 | 83 | 0.190 |
Why?
|
| Cardiac Catheterization | 2 | 2024 | 316 | 0.180 |
Why?
|
| Phlebography | 1 | 2020 | 70 | 0.180 |
Why?
|
| Pacemaker, Artificial | 2 | 1999 | 96 | 0.180 |
Why?
|
| Defibrillators, Implantable | 2 | 1999 | 146 | 0.170 |
Why?
|
| Ambulances | 1 | 1999 | 17 | 0.170 |
Why?
|
| Equipment Failure Analysis | 1 | 1999 | 91 | 0.160 |
Why?
|
| Cardiac Pacing, Artificial | 4 | 1995 | 103 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 602 | 0.130 |
Why?
|
| Recurrence | 4 | 2024 | 1162 | 0.130 |
Why?
|
| Procainamide | 1 | 1995 | 4 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 357 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 324 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2024 | 4348 | 0.120 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 1995 | 23 | 0.120 |
Why?
|
| Bundle of His | 1 | 1995 | 46 | 0.120 |
Why?
|
| Humans | 22 | 2024 | 90640 | 0.120 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 237 | 0.110 |
Why?
|
| Male | 17 | 2024 | 42967 | 0.100 |
Why?
|
| Moricizine | 1 | 1992 | 2 | 0.100 |
Why?
|
| Aged | 9 | 2024 | 19424 | 0.100 |
Why?
|
| Echocardiography | 1 | 2018 | 947 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 697 | 0.100 |
Why?
|
| Vasculitis | 1 | 2012 | 40 | 0.100 |
Why?
|
| Middle Aged | 13 | 2024 | 26347 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 2012 | 72 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2012 | 261 | 0.090 |
Why?
|
| Exercise | 1 | 1992 | 328 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 270 | 0.080 |
Why?
|
| Female | 12 | 2024 | 46894 | 0.070 |
Why?
|
| Observer Variation | 2 | 2020 | 615 | 0.070 |
Why?
|
| Time Factors | 3 | 2024 | 5366 | 0.070 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2004 | 16 | 0.060 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2024 | 54 | 0.060 |
Why?
|
| Operative Time | 1 | 2024 | 151 | 0.060 |
Why?
|
| Tidal Volume | 1 | 2023 | 54 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 1999 | 1709 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2782 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 1993 | 65 | 0.050 |
Why?
|
| Syncope | 1 | 2002 | 34 | 0.050 |
Why?
|
| Bundle-Branch Block | 1 | 2002 | 55 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6816 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2705 | 0.050 |
Why?
|
| Heart Block | 2 | 2012 | 31 | 0.050 |
Why?
|
| Action Potentials | 1 | 2024 | 602 | 0.040 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2020 | 22 | 0.040 |
Why?
|
| Exercise Test | 2 | 1992 | 168 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 9330 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3486 | 0.040 |
Why?
|
| Transportation of Patients | 1 | 1999 | 35 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 158 | 0.040 |
Why?
|
| Breath Holding | 1 | 2017 | 23 | 0.040 |
Why?
|
| Heart Rate | 1 | 1999 | 496 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 3698 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1362 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1873 | 0.030 |
Why?
|
| Artifacts | 1 | 2017 | 246 | 0.030 |
Why?
|
| Software | 1 | 1999 | 670 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 791 | 0.030 |
Why?
|
| Amiodarone | 1 | 1994 | 14 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 1999 | 792 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 5583 | 0.030 |
Why?
|
| Sotalol | 1 | 1993 | 3 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 1919 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2012 | 31 | 0.020 |
Why?
|
| Adult | 4 | 2020 | 26953 | 0.020 |
Why?
|
| Chest Pain | 1 | 2012 | 42 | 0.020 |
Why?
|
| Granuloma | 1 | 2012 | 64 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2012 | 45 | 0.020 |
Why?
|
| Electric Countershock | 1 | 1992 | 55 | 0.020 |
Why?
|
| Dyspnea | 1 | 2012 | 76 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1992 | 125 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1192 | 0.020 |
Why?
|
| Biomarkers | 1 | 2012 | 1800 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1994 | 27 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 360 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 2002 | 69 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 452 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 1216 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1608 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1994 | 403 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 2342 | 0.010 |
Why?
|
| Probability | 1 | 1994 | 357 | 0.010 |
Why?
|
| Flecainide | 1 | 1992 | 7 | 0.010 |
Why?
|
| Digoxin | 1 | 1992 | 21 | 0.010 |
Why?
|
| Verapamil | 1 | 1992 | 34 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1993 | 671 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1992 | 54 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1992 | 244 | 0.010 |
Why?
|
| Warfarin | 1 | 1992 | 104 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1993 | 482 | 0.010 |
Why?
|